Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
J Neurosurg Pediatr ; 18(2): 235-41, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27128787

ABSTRACT

OBJECTIVE Like adults, many children suffering from intractable seizures benefit from surgical therapy. Although various reports indicate that early intervention may avoid severe developmental consequences often associated with intractable epilepsy, surgery is still considered a last option for many children. In this retrospective study, the authors aimed to determine whether pediatric epilepsy surgery, in particular during the first years of life, relates to measurable benefits. METHODS Data from 78 patients (age range 5 months to 17 years) who underwent epilepsy surgery at the Geneva and Lausanne University Hospitals between 1997 and 2012 were reviewed retrospectively. Patients were dichotomized into 2 groups: infants (≤ 3 years of age, n = 19), and children/adolescents (4-17 years of age, n = 59). Compared with children/adolescents, infants more often had a diagnosis of dysplasia (37% vs 10%, respectively; p < 0.05, chi-square test). RESULTS The overall seizure-free rate was 76.9%, with 89.5% in infants and 72.9% in the children/adolescents group. Infants were 2.76 times as likely to achieve seizure-free status as children/adolescents. Postoperative antiepileptic medication was reduced in 67.9% of patients. Only 11.4% of the patients were taking more than 2 antiepileptic drugs after surgery, compared with 43% before surgery (p < 0.0001). The overall complication rate was 15.1% (6.4% transient hemiparesis), and no major complications or deaths occurred. CONCLUSIONS The data show a high seizure-free rate in children ≤ 3 years of age, despite a higher occurrence of dysplastic, potentially ill-defined lesions. Pediatric patients undergoing epilepsy surgery can expect a significant reduction in their need for medication. Given the excellent results in the infant group, prospective studies are warranted to determine whether age ≤ 3 years is a predictor for excellent surgical outcome.


Subject(s)
Epilepsy/diagnosis , Epilepsy/surgery , Adolescent , Age Factors , Child , Child, Preschool , Female , Follow-Up Studies , Humans , Infant , Male , Predictive Value of Tests , Retrospective Studies , Treatment Outcome
3.
Praxis (Bern 1994) ; 102(25): 1537-42, 2013 Dec 11.
Article in German | MEDLINE | ID: mdl-24326049

ABSTRACT

Positional plagiocephaly in the newborn corresponds to a posterior flattening and asymetry of the head. Its incidence has significantly increased since the "back to sleep" campain in the nineteen nineties to prevent sudden infant death syndrome. The posterior deformation usually worsens during the first six months of life when the skull is susceptible to posterior constant pressure which induces the deformation. Spontaneous outcome can be favorable. Treatment is always conservative and consists in positionnal exercise, physiotherapy and osteopathy. In some cases treatment with a helmet is recommended for a period of three months usually. Posterior positionnal plagiocephaly has no consequences on the brain's developement an is considered as an esthetic issue. In most cases good results are obtained after management with a custom fitted helmet when needed.


La palagiocéphalie positionnelle du nourisson se traduit le plus souvent par une asymétrie postérieure de la forme de la tête. L'incidence de la plagiocéphalie positionnelle a augmenté de manière significative depuis les années nonantes avec les campagnes menées pour prévenir la mort subite du nourisson en préconisant une position stricte sur le dos dans le berceau jusqu'à l'âge de six mois. La déformation postérieure visible s'aggrave en général au cours des six premiers mois de la vie, car le crâne est sensible à cet âge aux phénomènes de pressions constantes. L'évolution spontannée peut être favorable. Le traitement toujours conservateur peut consister en des manoeuvres de positionnement régulières, de l'ostéopathie ou du port d'un casque selon la sévérité de la déformation. C'est un problème esthétique sans conséquence sur le développement cérébrale. En général le traitement par casque sur mesure conduit à de bons résultats.


Subject(s)
Plagiocephaly, Nonsynostotic/diagnosis , Plagiocephaly, Nonsynostotic/therapy , Cross-Sectional Studies , Diagnosis, Differential , Head Protective Devices , Humans , Infant , Patient Positioning , Plagiocephaly, Nonsynostotic/epidemiology , Plagiocephaly, Nonsynostotic/etiology , Prognosis , Risk Factors , Supine Position
4.
J Neurosurg Pediatr ; 11(6): 658-60, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23581638

ABSTRACT

The authors report a case of a preterm infant at 29 weeks of gestation who gradually developed a Chiari malformation Type I (CM-I) with hydrocephalus due to a premature unilateral fusion of the posterior intraoccipital synchondrosis. Brain ultrasonography results in the 1st week of life were normal. Follow-up ultrasonography showed progressive development of triventricular hydrocephalus. Brain MRI demonstrated the presence of a CM-I and a deformation of the occipital bone. A complementary CT scan was obtained, showing a closure of the right posterior intraoccipital synchondrosis, resulting in a deformation of the posterior cranial fossa. This case shows the close relationship between a malformation of the skull base and the secondary development of a brain malformation. The authors discuss the anatomy of the occipital bone and suggest a probable theory for the premature closure of this synchondrosis and the consequent development of a CM-I. The originality of this case lies in the observation of the natural history of a brain malformation in a preterm infant.


Subject(s)
Arnold-Chiari Malformation/etiology , Craniosynostoses/complications , Hydrocephalus/etiology , Infant, Premature, Diseases/diagnosis , Infant, Premature , Occipital Bone/abnormalities , Osteochondrosis/complications , Skull Base/abnormalities , Arnold-Chiari Malformation/diagnostic imaging , Cranial Fossa, Posterior/abnormalities , Humans , Infant , Infant, Newborn , Infant, Premature, Diseases/diagnostic imaging , Infant, Premature, Diseases/pathology , Magnetic Resonance Imaging , Male , Occipital Bone/diagnostic imaging , Occipital Bone/growth & development , Skull Base/diagnostic imaging , Tomography, X-Ray Computed
5.
Childs Nerv Syst ; 29(10): 1927-31, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23559393

ABSTRACT

INTRODUCTION: Hypertrophy of the calvarium has different aetiologies, among them the rare Proteus syndrome. CASE REPORT: We report here the case of a young girl initially treated for relapsing right then left large chronic subdural haematoma, who progressively developed craniofacial hypertrophy consistent with the diagnosis of Proteus syndrome. Calvarium hypertrophy was shaved and remodelled combining midface advancement, essentially for cosmetic purposes. During the first calvarium remodelling, important bleeding of the bone required large volume of blood replacement. Haemostasis workup revealed platelets aggregation anomalies. Bleeding issues during subsequent surgeries were controlled with tranexamic acid and desmopressin acetate. DISCUSSION: Other manifestations of Proteus syndrome, such as a right hypertrophy of the face with hypoplasia of its middle third, a pigmented epidermal nevus and asymmetric limbs and scoliosis, appeared progressively over time. Blood and fibroblast phosphatase and tensin homolog mutation was not found. CONCLUSION: Literature review of operated patients with Proteus syndrome did not reveal an association with platelets anomalies. A complete haemostasis workup following this unexpected haemorrhagic complication is recommended for this rare pathology.


Subject(s)
Hematoma, Subdural/complications , Proteus Syndrome/complications , Child , Female , Humans , Proteus Syndrome/pathology
6.
Epilepsy Res ; 105(1-2): 245-9, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23375885

ABSTRACT

Traditionally, subcortical structures such as the cerebellum are supposed to exert a modulatory effect on epileptic seizures, rather than being the primary seizure generator. We report a 14-month old girl presenting, since birth, with seizures symptomatic of a right cerebellar dysplasia, manifested as paroxystic contralateral hemifacial spasm and ipsilateral facial weakness. Multimodal imaging was used to investigate both anatomical landmarks related to the cerebellar lesion and mechanisms underlying seizure generation. Electric source imaging (ESI) supported the hypothesis of a right cerebellar epileptogenic generator in concordance with nuclear imaging findings; subsequently validated by intra-operative intralesional recordings. Diffusion spectrum imaging-related tractography (DSI) showed severe cerebellar structural abnormalities confirmed by histological examination. We suggest that hemispheric cerebellar lesions in cases like this are likely to cause epilepsy via an effect on the facial nuclei through ipsilateral and contralateral aberrant connections.


Subject(s)
Cerebellar Cortex/abnormalities , Cerebellar Cortex/pathology , Cerebellar Diseases/diagnosis , Epilepsy/diagnosis , Hemifacial Spasm/diagnosis , Adolescent , Cerebellar Diseases/complications , Epilepsy/etiology , Female , Hemifacial Spasm/etiology , Humans
8.
J Neurosurg Pediatr ; 5(5): 523-8, 2010 May.
Article in English | MEDLINE | ID: mdl-20433268

ABSTRACT

In this report, the authors describe 4 recent cases of posterior giant dural venous sinus ectasia in neonates diagnosed during pregnancy and encountered at 3 different institutions. Posterior giant venous sinus ectasia was diagnosed in 4 patients using antenatal ultrasonography and confirmed in 2 patients using prenatal MR imaging and in 3 patients using postnatal MR angiography. In 2 children angiography was performed at the age of 6 months. The pregnancy was terminated in 1 case, and the fetus underwent an autopsy. The 3 children who were born presented with various degree of cardiac insufficiency and were admitted to the intensive care unit after birth. Signs of increased intracranial pressure were present immediately after birth, including a bulging fontanel. No endovascular treatment was used in these cases. Surgery was performed in 2 cases as an attempt to alleviate increased intracranial pressure symptoms, without any real benefit. A slow venous flow in the ectasia was shown by ultrasonography in the case in which the pregnancy was terminated. Angiography or MR angiography did not show an obvious arteriovenous malformation in any of the cases, but an arteriovenous fistula secondary or contributing to the formation of the venous ectasia is one of the physiopathological hypotheses of the cause of this condition. Interestingly, spontaneous progressive thrombosis and regression of the intravascular component of the venous sinus ectasia was observed in all cases. The clinical outcome was acceptable in 1 child (who had a moderate handicap after the surgery) and good for the other 2 children (who had normal neurological development). Stratified thrombi of different ages are found in these giant venous ectasias and develop within the leaves of the dura close to the confluence of the major posterior venous sinuses. Therefore, it appears that the formation of a progressive thrombosis represents the normal evolution of these giant dural venous sinus ectasias, which explains the favorable outcome in some cases without specific surgical treatment, except for resuscitation techniques.


Subject(s)
Cranial Sinuses/abnormalities , Magnetic Resonance Angiography , Magnetic Resonance Imaging , Prenatal Diagnosis , Ultrasonography, Prenatal , Adult , Cerebral Angiography , Cranial Sinuses/pathology , Decompression, Surgical , Dilatation, Pathologic , Disabled Children , Female , Humans , Infant , Infant, Newborn , Male , Neurologic Examination , Neuropsychological Tests , Postoperative Complications/etiology , Pregnancy , Pregnancy Trimester, Third , Prognosis , Sinus Thrombosis, Intracranial/diagnosis , Sinus Thrombosis, Intracranial/surgery
9.
Stem Cells ; 27(6): 1309-17, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19489096

ABSTRACT

Stem/progenitor cell-based therapies hold promises for repairing the damaged nervous system. However, the efficiency of these approaches for neuronal replacement remains very limited. A major challenge is to develop pretransplant cell manipulations that may promote the survival, engraftment, and differentiation of transplanted cells. Here, we investigated whether overexpression of fibroblast growth factor-2 (FGF-2) in grafted neural progenitors could improve their integration in the host tissue. We show that FGF-2-transduced progenitors grafted in the early postnatal rat cortex have the distinct tendency to associate with the vasculature and establish multiple proliferative clusters in the perivascular environment. The contact with vessels appears to be critical for maintaining progenitor cells in an undifferentiated and proliferative phenotype in the intact cortex. Strikingly, perivascular clusters of FGF-2 expressing cells seem to supply immature neurons in an ischemic environment. Our data provide evidence that engineering neural progenitors to overexpress FGF-2 may be a suitable strategy to improve the integration of grafted neural progenitor cells with the host vasculature thereby generating neurovascular clusters with a neurogenic potential for brain repair.


Subject(s)
Fibroblast Growth Factor 2/biosynthesis , Hypoxia-Ischemia, Brain/surgery , Neurons/metabolism , Stem Cell Transplantation/methods , Stem Cells/metabolism , Animals , Blood Vessels , Cell Differentiation/physiology , Fibroblast Growth Factor 2/genetics , Immunohistochemistry , Neurons/cytology , Rats , Rats, Wistar , Stem Cells/cytology
10.
Neurochem Res ; 33(7): 1325-31, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18270817

ABSTRACT

We measured perioperative plasma concentrations of brain-derived neurotrophic factor (BDNF), a major mediator of synaptic plasticity in the central nervous system, in males, 30-65 years old, undergoing lumbar or cervical discotomy. Patients were randomly allocated to a general anesthetic with propofol induction and maintenance or with thiopental induction and isoflurane maintenance. BDNF plasma concentrations were measured before induction (baseline), 15 min after induction but before start of surgery, at skin closure, in the post-anesthetic care unit, and 24 h postoperatively. Data from 26 patients (13 in each group) were analyzed. At each time point, BDNF plasma concentrations showed large variability. At baseline, concentrations were 631 +/- 337 (mean +/- SD) pg ml(-1) in the propofol group and were 549 +/- 512 pg ml(-1) in the thiopental-isoflurane group (P = 0.31). At 15 min, concentrations significantly decreased in the propofol group (247 +/- 219 pg ml(-1), P = 0.0012 compared with baseline) but remained unchanged in the thiopental-isoflurane group (597 +/- 471 pg ml(-1), P = 0.798 compared with baseline). At skin closure and in the post-anesthetic care unit, concentrations were not different from baseline in both groups. At 24 h, concentrations significantly decreased below baseline in both groups (propofol: 232 +/- 129 pg ml(-1), P = 0.0015; thiopental-isoflurane: 253 +/- 250 pg ml(-1), P = 0.016). In the propofol group, there was a weak but statistically significant positive correlation (R2 = 0.38, P = 0.026) between the duration of surgery and BDNF plasma concentrations at skin closure. These data suggest that in males undergoing elective minor surgery, BDNF plasma concentrations show a specific pattern that is influenced by the anesthetic technique and, possibly, by the duration of surgery.


Subject(s)
Brain-Derived Neurotrophic Factor/blood , Surgical Procedures, Operative , Adult , Aged , Aging , Anesthesia, General , Anesthesia, Intravenous , Anesthetics, Inhalation , Anesthetics, Intravenous , Body Mass Index , Diskectomy , Humans , Hypnotics and Sedatives , Isoflurane , Male , Middle Aged , Postoperative Period , Propofol , Thiopental
11.
J Neurosurg ; 107(4 Suppl): 307-13, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17941496

ABSTRACT

The PTEN hamartoma tumor syndrome, manifestations of which include Cowden disease and Bannayan-Riley-Ruvalcaba syndrome, is caused by various mutations of the PTEN gene located at 10q23. Its major criteria are macrocephaly and a propensity to develop breast and thyroid cancers as well as endometrial carcinoma. Minor diagnostic criteria include hamartomatous intestinal polyps, lipomas, fibrocystic disease of the breasts, and fibromas. Mutations of PTEN can also be found in patients with Lhermitte-Duclos disease (dysplastic gangliocytoma of the cerebellum). The authors report the case of a 17-year-old girl who had a severe cyanotic cardiac malformation for which surgery was not advised and a heterozygous missense mutation (c.406T>C) in exon 5 of PTEN resulting in the substitution of cysteine for arginine (p.Cysl36Arg) in the protein, which was also found in her mother and sister. The patient presented in the pediatric emergency department with severe spastic paraparesis. A magnetic resonance imaging study of the spine showed vertebral hemangiomas at multiple levels, but stenosis and compression were maximal at level T5-6. An emergency T5-6 laminectomy was performed. The decompression was extremely hemorrhagic because the rapid onset of paraparesis necessitated prompt treatment, and there was no time to perform preoperative embolization. The patient's postoperative course was uneventful with gradual recovery. This represents the first report of an association of a PTEN mutation and multiple vertebral angiomas. The authors did not treat the remaining angiomas because surgical treatment was contraindicated without previous embolization, which in itself would present considerable risk in this patient with congenital cyanotic heart disease.


Subject(s)
Hamartoma Syndrome, Multiple/genetics , Hemangioma/genetics , Mutation, Missense , PTEN Phosphohydrolase/genetics , Paraparesis/etiology , Spinal Neoplasms/genetics , Adolescent , Angiography , Arginine , Cyanosis/congenital , Cyanosis/etiology , Cysteine , Decompression, Surgical , Female , Hamartoma Syndrome, Multiple/diagnosis , Heart Defects, Congenital/complications , Hemangioma/complications , Hemangioma/diagnosis , Hemangioma/surgery , Heterozygote , Humans , Magnetic Resonance Imaging , Severity of Illness Index , Spinal Cord Compression/complications , Spinal Cord Compression/etiology , Spinal Cord Compression/physiopathology , Spinal Neoplasms/complications , Spinal Neoplasms/diagnosis , Spinal Neoplasms/surgery , Thoracic Vertebrae , Tomography, X-Ray Computed
12.
Brain ; 130(Pt 11): 2962-76, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17728358

ABSTRACT

Strategies to enhance the capacity of grafted stem/progenitors cells to generate multipotential, proliferative and migrating pools of cells in the postnatal brain could be crucial for structural repair after brain damage. We investigated whether the over-expression of basic fibroblast growth factor 2 (FGF-2) in neural progenitor cells (NPCs) could provide a robust source of migrating NPCs for tissue repair in the rat cerebral cortex. Using live imaging we provide direct evidence that FGF-2 over-expression significantly enhances the migratory capacity of grafted NPCs in complex 3D structures, such as cortical slices. Furthermore, we show that the migratory as well as proliferative properties of FGF-2 over-expressing NPCs are maintained after in vivo transplantation. Importantly, after transplantation into a neonatal ischaemic cortex, FGF-2 over-expressing NPCs efficiently invade the injured cortex and generate an increased pool of immature neurons available for brain repair. Differentiation of progenitor cells into immature neurons was correlated with a gradual down-regulation of the FGF-2 transgene. These results reveal an important role for FGF-2 in regulating NPCs functions when interacting with the host tissue and offer a potential strategy to generate a robust source of migrating and immature progenitors for repairing a neonatal ischaemic cortex.


Subject(s)
Cerebral Cortex/injuries , Fibroblast Growth Factor 2/metabolism , Stem Cells/metabolism , Wound Healing , Animals , Animals, Newborn , Cell Movement , Cell Proliferation , Cerebral Cortex/chemistry , Cerebral Cortex/pathology , Fibroblast Growth Factor 2/analysis , Fibroblast Growth Factor 2/genetics , Gene Expression , Genetic Engineering , Genetic Vectors/administration & dosage , Genetic Vectors/genetics , HIV-1/genetics , Humans , Hypoxia-Ischemia, Brain/surgery , Immunohistochemistry , Microscopy, Fluorescence , Models, Animal , Rats , Rats, Sprague-Dawley , Stem Cell Transplantation/methods , Stem Cells/pathology , Transduction, Genetic/methods , Transgenes
13.
Development ; 134(6): 1181-90, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17301083

ABSTRACT

In the mammalian brain, ongoing neurogenesis via the rostral migratory stream (RMS) maintains neuronal replacement in the olfactory bulb throughout life. Mechanisms that regulate the final number of new neurons in this system include proliferation, migration and apoptosis. Here we show that the polysialylated isoforms of the neural cell adhesion molecule (PSA-NCAM) act as a pro-survival molecule in immature newborn neurons. Confocal microscopic analysis revealed a threefold increase in TUNEL-positive cells in the subventricular zone (SVZ) and the RMS of transgenic animals lacking the gene encoding NCAM (NCAM(-/-)), as compared with wild types. The enhanced apoptotic cell death occurred specifically in the population of mCD24-positive newborn neurons, but not in GFAP-positive astrocytes. Using in vitro cultures of purified SVZ-derived neurons, we demonstrate that the loss or inactivation of PSA on NCAM, as well as the deletion of NCAM, lead to reduced survival in response to neurotrophins including BDNF and NGF. These changes in cell survival are accompanied by an upregulation of p75 neurotrophin receptor expression in vitro as well as in vivo. Furthermore, the negative effects of PSA-NCAM inactivation on cell survival could be prevented by the pharmacological blockade of the p75 receptor-signaling pathway. We propose that PSA-NCAM may promote survival by controlling the expression of the p75 receptor in developing neurons.


Subject(s)
Apoptosis/genetics , Neural Cell Adhesion Molecule L1/physiology , Neurons/metabolism , Olfactory Bulb/growth & development , Receptor, Nerve Growth Factor/metabolism , Sialic Acids/physiology , Animals , Cell Survival/genetics , Mice , Mice, Transgenic , Nerve Growth Factors/pharmacology , Neural Cell Adhesion Molecule L1/genetics , Neurons/cytology , Neurons/drug effects , Olfactory Bulb/cytology , Olfactory Bulb/metabolism , Rats , Rats, Sprague-Dawley , Receptor, Nerve Growth Factor/genetics , Sialic Acids/genetics
14.
J Neurosci ; 26(50): 12956-66, 2006 Dec 13.
Article in English | MEDLINE | ID: mdl-17167085

ABSTRACT

The initial formation and growth of dendrites is a critical step leading to the integration of newly generated neurons into postnatal functional networks. However, the cellular mechanisms and extracellular signals regulating this process remain mostly unknown. By directly observing newborn neurons derived from the subventricular zone in culture as well as in olfactory bulb slices, we show that ambient GABA acting through GABA(A) receptors is essential for the temporal stability of lamellipodial protrusions in dendritic growth cones but did not interfere with filopodia dynamics. Furthermore, we provide direct evidence that ambient GABA is required for the proper initiation and elongation of dendrites by promoting the rapid stabilization of new dendritic segments after their extension. The effects of GABA on the initial formation of dendrites depend on depolarization and Ca2+ influx and are associated with a higher stability of microtubules. Together, our results indicate that ambient GABA is a key regulator of dendritic initiation in postnatally generated olfactory interneurons and offer a mechanism by which this neurotransmitter drives early dendritic growth.


Subject(s)
Dendrites/physiology , Growth Cones/physiology , Interneurons/physiology , Olfactory Bulb/growth & development , Pseudopodia/physiology , gamma-Aminobutyric Acid/physiology , Animals , Animals, Newborn , Cells, Cultured , GABA-A Receptor Agonists , Rats , Rats, Sprague-Dawley , Receptors, GABA-A/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...